James Parker
Latest MedTruth Work by James Parker
Nearly 70 Paraquat Lawsuits Filed, Alleg...
James Parker · May 10, 2021
In early April, two plaintiffs filed a request for multidistrict litigation against paraquat manufacturers, including Syngenta.
Legal DevelopmentsBellwether Trials: What You Need to Know
James Parker · April 8, 2021
MedTruth's guide to bellwether trials, including their importance and notable examples.
Legal DevelopmentsBaby Food Companies Sued for Toxic Heavy...
James Parker · March 23, 2021
A group of parents has requested that the Judicial Panel on Multidistrict Litigation consolidate their cases in federal district court.
Legal Developments-
Nearly 70 Paraquat Lawsuits Filed, Alleg...
James Parker · May 10, 2021
In early April, two plaintiffs filed a request for multidistrict litigation against paraquat manufacturers, including Syngenta.
Legal Developments -
Bellwether Trials: What You Need to Know
James Parker · April 8, 2021
MedTruth's guide to bellwether trials, including their importance and notable examples.
Legal Developments -
Baby Food Companies Sued for Toxic Heavy...
James Parker · March 23, 2021
A group of parents has requested that the Judicial Panel on Multidistrict Litigation consolidate their cases in federal district court.
Legal Developments
FDA Acts to Protect Consumers from Fake "FDA Certified" Health Care Products
James Parker · March 9, 2021
The FDA sent letters to 25 printing firms to stop producing fake “FDA registration certificates.”
FDA RegulationClass Action Lawsuits: What You Need to Know
James Parker · February 24, 2021
MedTruth's guide to class action lawsuits, from the basics to how the process works.
Legal DevelopmentsCOVID-19 Nursing Home Lawsuit Protections: Early 2021 State Updates
James Parker · January 22, 2021
A roundup of updates on COVID-19 nursing home lawsuits.
Legal Developments$2.1 Billion Talcum Powder Cancer Verdict Stands, J&J Appealing to Supreme Court
James Parker · November 12, 2020
Johnson & Johnson intends to appeal a record $2.1 billion talc verdict after striking out in the Missouri Supreme Court.
Legal DevelopmentsFDA Warns Against Dental Amalgams for Groups Sensitive to Mercury
James Parker · October 26, 2020
Certain individuals are instructed to avoid getting “silver” fillings due to mercury exposure concerns.
FDA RegulationFDA Recommends Black Box Warning on Breast Implants
James Parker · October 2, 2020
The FDA has issued a final warning label and new guidance to inform patients of the potential risks associated with breast implants.
Women's HealthGet our reporting in your inbox
Golf Pro Sues Monsanto, Claims Roundup Caused Cancer
James Parker · September 16, 2020
A Washington state golf pro who says Roundup caused his cancer has filed a lawsuit against Monsanto.
Legal DevelopmentsJohnson & Johnson Talc Appeal Reaches Missouri Supreme Court
James Parker · September 11, 2020
J&J is asking the Missouri Supreme Court to overturn a multibillion-dollar ruling that affirmed that asbestos and carcinogens in its talc products caused cancer in 22 women.
Legal DevelopmentsElmiron Lawsuits Claim Drug Companies Knowingly Withheld Risks
James Parker · August 25, 2020
Two women allege that drug manufacturers knowingly withheld information about harm caused by long-term use of Elmiron.
Legal DevelopmentsAdditional Metformin Lots Voluntarily Recalled Due to Contamination Concerns
James Parker · July 16, 2020
The FDA issued a pair of new recall alerts for select extended-release batches of metformin, a popular drug used to control type 2 diabetes.
FDA Regulation“STINK!” Exposes the Odious Chemical Practices of Corporations in America
James Parker · July 10, 2020
The documentary STINK! follows the personal story of how Jon J Whelan became involved in activism against toxic chemicals.
Health FeaturesPPI and Dementia Potentially Linked In New Study
James Parker · July 6, 2020
A recent study published in Alzheimer’s & Dementia, the journal of the Alzheimer’s Association, investigated the methods by which proton pump inhibitors and dementia are connected.
Research + FindingsGBCA Chemical Toxicity Suit Weathers Dismissal Claims
James Parker · July 2, 2020
The plaintiff claims that the GBCAs used in her MRIs in 2015 caused a condition known as gadolinium deposition disease (GDD) and a host of debilitating side effects.
Legal DevelopmentsZofran Bellwether Delay Pushes Proceedings to 2021
James Parker · June 29, 2020
The multidistrict Zofran litigation has been further delayed to 2021 due to coronavirus concerns.
Legal DevelopmentsAdverse Event Reporting Resumes After COVID Hiatus
James Parker · June 24, 2020
The slowdown in adverse event reporting can be attributed to an official regulatory pause for a period of two months.
FDA RegulationCalifornia Attorneys Seek to Consolidate Zantac Lawsuits
James Parker · June 12, 2020
Attorneys representing 40 plaintiffs in California have recently filed a petition to consolidate product liability cases against the manufacturers of the heartburn medication Zantac, which may cause cancer.
Legal DevelopmentsTobacco Companies Challenge LA County Vape Ban in California Federal Court
James Parker · June 10, 2020
A group of tobacco companies is pushing to legally overturn the Los Angeles County ban on flavored vape fluid, alleging the action is unconstitutional and unenforceable.
Legal DevelopmentsFDA Singulair Warning Cautions Patients of Psychiatric Risks
James Parker · June 9, 2020
The FDA Singulair warning addressed a troubling connection between the medication and an increased risk of neuropsychiatric events, including agitation and depression.
FDA RegulationRemdesivir Study Muddies Waters For Medical Authorities
James Parker · June 3, 2020
COVID-19 patients administered the investigational antiviral drug remdesivir were 65% more likely to exhibit clinical improvement according to preliminary research findings announced Monday by Gilead Sciences, a California-based biopharmaceutical company.
Research + FindingsNew York State Courts Gradually Reopening
James Parker · May 22, 2020
Courts in New York City starting the next stage of re-opening, allowing for electronic filing of non-essential legal matters using the New York State Electronic Filing System (NYSCEF).
Legal DevelopmentsNursing Home Execs May Lose COVID-19 Liability Protections
James Parker · May 21, 2020
Newly introduced legislation could unravel legal protections recently afforded nursing home executives and administrators in New York.
Legal DevelopmentsJohnson & Johnson Faces Elmiron Lawsuit for Allegedly Concealing Adverse Event Data
James Parker · May 18, 2020
A recent legal complaint filed in May by a Nevada woman named Tina Pisco claims Elmiron, a drug for interstitial cystitis, caused her to develop maculopathy — a degenerative disease of the retina that may permanently damage vision.
Legal DevelopmentsStates Enact Controversial Lawsuit Protections for Nursing Homes
James Parker · May 13, 2020
The nursing home industry has grown increasingly concerned about a potential onslaught of COVID-related lawsuits and has begun pushing for legal protection from what it says are crisis conditions beyond its control.
Laws + CongressAfter 9 Months, Daubert Ruling on Talcum Powder-Cancer is Released
James Parker · May 1, 2020
The recent Daubert opinion, written by presiding Judge Wolfson after a nine-month deliberation, is a crucial ruling on the validity of the methods used by the expert scientific witnesses testifying in the talcum powder and ovarian cancer multi-district litigation.
Legal DevelopmentsMT Weekly: At-Home COVID Test Kits, Anti-Malarial Drug Side Effects
James Parker · April 24, 2020
MedTruth is highlighting this week's coronavirus-related updates. The FDA warns the public not to use anti-malarial drugs outside of hospitals, the agency approved an at-home coronavirus test collection kit, and the CDC predicts a second wave of infections as the nation reopens.
NewsNew Opioid Lawsuit Filings May Be on the Horizon
James Parker · April 21, 2020
More than 2,700 multidistrict-litigations are still pending in Ohio federal court, while new opioid lawsuit filings are being bounced back to local and tribal governments.
Legal DevelopmentsMT Weekly: FDA Fast-Tracks Coronavirus Saliva Test, CDC Guidance For Workers’ Return
James Parker · April 16, 2020
MedTruth is highlighting this week's coronavirus-related updates. A COVID saliva test has been fast-tracked, federal guidelines for relaxing social distancing, and how warm weather will — or wont — affect the coronavirus.
NewsCME Pump Recall Initiated For Inaccurate Medication Dispensing
James Parker · April 13, 2020
CME America’s BodyGuard Infusion Pump Systems have been recalled due to potentially fatal defects in medication dispersal.
FDA RegulationFDA Pipeline Recall Initiated to Protect Aneurysm Patients
James Parker · April 9, 2020
The FDA has recalled Medtronic's Pipeline Flex Embolization products after the organization discovered that the device could fracture during or after placement.
FDA RegulationNursing Home Residents Remain at Risk From Coronavirus Despite Lockdowns
James Parker · April 7, 2020
Nursing homes are closed to all outside visitors and nonessential staff to protect residents from COVID-19, but they are still vulnerable to infection spread by staff members.
NewsFDA Warns Patients to Stop Taking SGLT-2 Inhibitors Before Surgery
James Parker · April 3, 2020
The FDA released a warning about continuing the use of sodium-glucose co-transporter-2 inhibitors before surgery, informing patients that the class of diabetes medications could contribute to a higher risk of ketoacidosis.
FDA RegulationE-Cigarette Deadline Postponement Requested Amid COVID-19 Uncertainty
James Parker · April 1, 2020
The FDA filed a request with the courts to postpone the deadline for e-cigarette makers to prepare approval and testing justifications, a decision motivated by complications arising from COVID-19.
NewsJ&J COVID-19 Contract Allocates $456 Million For Vaccine Research
James Parker · March 31, 2020
J&J signed a COVID-19 contract with the U.S. government for vaccine research, becoming the largest monetary amount spent on a vaccine project in history, despite not yet having a product in production.
NewsJohnson & Johnson Talc Appeal Unhindered by COVID-19 Shutdown
James Parker · March 30, 2020
A Missouri appellate court set an April 24 date for Johnson & Johnson’s $4.69 billion talc appeal, despite the Missouri Supreme Court’s cancellation of all April arguments to reduce COVID-19 exposure.
Legal DevelopmentsNY Coronavirus Restrictions Permit "Essential" Legal Work
James Parker · March 27, 2020
With the recent order to increase social distancing protocols in New York, law firms are not considered an "essential business." However, specific types of legal work are deemed essential, such as emergency family hearings and criminal cases.
NewsZofran Bellwether Delay Halts Litigatory Momentum
James Parker · March 27, 2020
The first bellwether trial in the multidistrict litigation involving Zofran, an anti-nausea medication that may cause birth defects, has been indefinitely postponed.
Legal DevelopmentsFDA Finds Asbestos in Cosmetics, Consumer Protection Bill Introduced
James Parker · March 25, 2020
The FDA's year-long probe into potential asbestos contamination in talc-containing cosmetic products and baby powder is over, and the results are in: contamination was found in 9 out of 52 samples.
FDA RegulationResearch Suggests Elmiron May Cause Complications With Vision
James Parker · March 19, 2020
Studies have shown an association between Elmiron complications and retinal abnormalities, which may cause difficulty in reading and adapting to changes in light.
Research + FindingsUnderstanding the Coronavirus: Myths & Prevention
James Parker · March 10, 2020
An overview of coronavirus symptoms, prevention measures, resources and myths debunked.
NewsFDA Bans Electrical Stimulation Devices After Identifying Substantial Risk
James Parker · March 5, 2020
The FDA has banned electrical stimulation devices, used for self-injurious or aggressive behavior, due to significant psychological and physical risks.
FDA RegulationCorporations Accused of Allowing Excess NDMA in Zantac MDL
James Parker · March 4, 2020
A Zantac multidistrict litigation hearing was held to decide how to proceed with over 100 lawsuits filed alleging that the makers of Zantac and its counterparts concealed fatal defects in the drug’s ingredients.
Legal Developments38 States Unite to Investigate JUUL Labs
James Parker · February 27, 2020
State attorneys general are leading a probe into whether Juul had illicitly marketed its e-cigarettes as smoking cessation aids despite not being approved by federal regulators for that purpose.
Laws + CongressJ&J Fined More Than $180 Million for Asbestos Contamination
James Parker · February 6, 2020
A New Jersey jury imposed a now-reduced verdict of three-quarters of a million dollars in punitive fines to Johnson & Johnson.
Legal DevelopmentsCalifornia Ethicon Mesh Judgement Results in $344 Million Fine for J&J
James Parker · January 30, 2020
Johnson & Johnson's subsidiary is set to pay $344 million for failing to inform consumers about the risks of transvaginal mesh.
Legal DevelopmentsEthicon Stapler Recall Removes Over 90,000 Units From Circulation
James Parker · January 27, 2020
The FDA is enforcing an Ethicon stapler recall after units were ejecting malformed staples.
FDA RegulationFDA Gabapentinoid Warning Focuses on Respiratory Complications
James Parker · January 21, 2020
The FDA issued a warning about respiratory depression and serious breathing difficulties in patients using gabapentin. Certain factors, including pre-existing respiratory complications and opioid use, may increase the risk.
FDA RegulationBoynton Beach Zantac Lawsuit Filed by Local Woman
James Parker · January 15, 2020
A Florida woman has filed a lawsuit alleging that Zantac manufacturers deliberately allowed an unsafe product to remain on the market.
Legal DevelopmentsFDA Metformin Probe Investigates Potential NDMA Hazard
James Parker · January 8, 2020
An investigation will determine whether the diabetes drug metformin contains dangerously elevated levels of the carcinogen NDMA, as part of a larger movement to examine a wide spectrum of medications for unsafe levels of contamination.
FDA RegulationFDA Schedules Public Meeting to Assess Testing for Asbestos in Talc
James Parker · January 13, 2020
The public meeting may be crucial to qualifying expert witnesses for thousands of plaintiffs involved in national talcum powder cases.
FDA RegulationMore Companies Pull Heartburn Meds to Participate in FDA Ranitidine Recall
James Parker · January 13, 2020
Appco Pharma and Denton Pharma have voluntarily recalled generic versions of Zantac (ranitidine) to align with the FDA's efforts to remove drugs from circulation that may contain more than 96 nanograms of NDMA per million nanograms of ranitidine.
FDA RegulationPREVENT Vaping Act Seeks to Educate Teens About E-Cigarettes
James Parker · January 8, 2020
PREVENT, a bill introduced in the U.S. House of Representatives, intends to end the vaping epidemic among teens by supporting CDC efforts to educate youth about associated risks.
Laws + CongressJohnson & Johnson Settlement Abruptly Concludes California Talc Trial
James Parker · January 7, 2020
Johnson & Johnson and plaintiffs Linda and Mark O’Hagan reached a midtrial settlement without jury verdict, meaning the jury will not be given an opportunity to make a decision that considers the FDA's finding of asbestos in talcum powder.
Legal DevelopmentsLos Angeles Jury Rules in Favor of Johnson & Johnson in Talc Mesothelioma Lawuit
James Parker · December 17, 2019
A jury in Los Angeles found Johnson & Johnson is not liable for causing Pui "Amy" Fong's mesothelioma, deciding its Baby Powder product was not defective nor a substantial threat.
Legal DevelopmentsFDA Approves First Single-Use, Disposable Duodenoscope
James Parker · January 6, 2020
The Exalt Model D, manufactured by Boston Scientific, is the first single-use duodenoscope approved for physicians.
FDA RegulationMassachusetts Passes Vaping Tax, Bans Mint and Menthol Tobacco Products
James Parker · December 9, 2019
A bill imposing a vaping tax and limiting the sale of mint and menthol flavored tobacco products has passed in Massachusetts.
Laws + CongressFDA Warns CBD Companies For Violating Federal Law
James Parker · December 4, 2019
The FDA sent warning letters to 15 companies regarding the illegal sale of CBD products.
FDA RegulationBirth Defects in Zofran Litigation Disputed, Despite Evidence Removed
James Parker · November 13, 2019
Recent litigation on Zofran has called into question expert testimony, which was removed from the evidence indicating that Zofran causes birth defects when used by pregnant women. Drug manufacturer, GlaxoSmithKline denies that causation of complications beyond heart defects and cleft palate can be proved. Though five cases were removed from the compilation of suits against GSK, the court proceedings wage on -- calling into question whether or not GSK should be required to update their product labeling with an adequate warning.
Legal DevelopmentsMT Weekly: Australia Fights BIA-ALCL, Ireland Refuses Recourse to Mesh-Injured
James Parker · October 21, 2019
Last week in medical brought about delay in an opioid trial against Purdue Pharmaceuticals and the Sackler family while the two determine how much of the settlement the Sacklers should pay. Meanwhile, actions were made against BIA-ALCL in Australia and Ireland, where warnings were sent to the public. Ireland's mesh-injured population is denied financial compensation for their harm.
NewsMT Weekly: Research Sheds Light on BIA-ALCL, Australia Joins Litigation Against Monsanto
James Parker · October 14, 2019
Groundbreaking new research on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) reveals complete removal of tumor growth during explant procedures may be safest. Meanwhile, limits on nicotine levels in e-cigarettes are proposed to protect the youth and Australia takes action against Monsanto.
NewsMT Weekly: Descovy Approved for PrEP, Overseas Action Against Breast Implants
James Parker · October 7, 2019
Johnson & Johnson sidesteps opioid trials, agreeing to a settlement of $20.4 million for affected counties in Ohio. Meanwhile, Descovy has been approved by FDA for HIV prevention, a court verdict falls in favor of California couple affected by J& J talc powder, and more bans are proposed on e-cigarattes and breast implants.
NewsMT Weekly: Arrests on Devil’s Highway and JUUL Labs’ New CEO
James Parker · September 30, 2019
Last week saw 38 arrests in Massachusetts along land known as the "Devil's Highway," where opioids are regularly sold. Meanwhile, Johnson & Johnson aims to evade cases against their talcum powder and transvaginal mesh to no avail. JUUL Labs' new CEO, Crosthwaite, has announced roll back on television ads and lobbying efforts while a federal investigation of their company is conducted. And in the fight against HIV, researchers may have found a new way to combat dormant HIV cells.
NewsMT Weekly: J&J Mistrial Declared, 'No JUULS' Requested for Schools
James Parker · September 16, 2019
In this week's MT Weekly, Purdue Pharma and the Sacklers negotiated settlements, while pharmaceutical manufacturer Mallinckrodt agreed to a $30 million settlement. Trials on talc and Roundup brought stalemates. Still, global HIV efforts and criticisms of JUUL e-cigarettes bring hope for public health.
Health FeaturesMT Weekly: Robotic Devices for Breast Implants, Public Figures Protesting JUUL
James Parker · September 9, 2019
Our current installment of MT Weekly has updates on opioid epidemic initiatives, the J&J talcum powder trial, breast implant improvements, protests against JUUL and advancements in HIV research.
Health FeaturesMT Weekly: Sackler Family Subpoenas, JUUL's Global Strategy, Momentous HIV Breakthroughs
James Parker · August 27, 2019
Last week, the state of New York issued subpoenas to companies with relations to the Sackler family in attempts to track money spent on opioids. Additionally, JUUL announced interest in global markets, and HIV researchers discovered a potentially illuminating sample of the virus.
Health FeaturesMT Weekly: California Roundup Warnings, HIV Treatment Drawbacks, JUUL Sues FDA
James Parker · August 19, 2019
In recent news, Roundup will no longer be labeled as carcinogenic in California. Meanwhile, JUUL files suit against the FDA to delay inspection of their e-cigarette. Medicare defraud, talc trial asbestos denials and issues surrounding access to HIV prevention medication are also covered.
Health FeaturesFDA Will Add Graphic Warning Labels to Cigarette Packages
James Parker · August 15, 2019
On Aug. 15, the U.S. Food and Drug Administration released a new rule requiring warning labels on cigarette boxes. Full-color cigarette warnings must be included on all cartons with images of side effects, including blindness, amputation and bladder cancer.
FDA RegulationFirst New Mesothelioma Treatment in 15 Years Approved by FDA
James Parker · August 8, 2019
Manufactured by Novocure, the FDA-approved mesothelioma treatment, NovoTTF-100L is the newest option for MPM since Pemetrexed. NovoTTF-100L was approved under the FDA Humanitarian Device Exemption, which is an expedited regulatory pathway intended to approve treatments for rare diseases.
FDA RegulationMT Weekly: JUUL Addresses Concerns, Bayer Faces Setbacks, Taiwan to Ban Transvaginal Mesh
James Parker · August 2, 2019
In this week's health news, JUUL addresses health concerns raised by Yale University's recent research findings on the well-known e-cigarette product. Meanwhile, Bayer stock drops as the company faces more litigation and transvaginal mesh bans are discussed in the U.S. and abroad.
Health FeaturesSeven Plaintiffs Refile J&J Talc Lawsuit to Prosecute Claire's and Others
James Parker · August 1, 2019
Judge George H. Wu of California granted case dismissal to seven plaintiffs in a talc lawsuit against Johnson & Johnson for their failure to label talc products. The plaintiffs will refile - adding more cases to their complaint and holding other companies liable.
Legal DevelopmentsMarketing Tactics Mislead Consumers, Says Latest Testimony Against J&J Mesh
James Parker · July 31, 2019
In the latest transvaginal mesh trial, led by California Attorney General Xavier Becerra, expert testimony speaks to the way Johnson & Johnson's advertisements mislead consumers. Surgeon Margolis believes their mesh causes "substantial, significant, irreversible damage," despite consumer-friendly ads.
Legal DevelopmentsMT Weekly: Historic Breast Implant Recall, Talc Trials Kept in State Courts
James Parker · July 26, 2019
In this week's news, Johnson & Johnson is officially denied transfer into federal court and Allergen announces breast implant recall from the market worldwide. Meanwhile, the opioid crisis wages on, California's latest mesh trial proceeds, and solutions for HIV are sought around the globe.
NewsMT Weekly: Surprising Opioid Stats, HIV Research Strides and Stalled Zofran Litigation
James Parker · July 18, 2019
In this week's MT Weekly, recently published opioid statistics reveal that prescriptions for opioids are actually down by a notable percentage. Additionally, successful treatment methods for HIV are underway, and Zofran litigation is stalled by the pharmaceutical company's request for an FDA statement.
Health FeaturesMT Weekly: Roundup Bans, Breast Implant Research and Medical Device Laws
James Parker · July 9, 2019
In recent news, Austria bans RoundUp while a U.S. judge orders a reduction of the $75 million punitive settlement. Numbers indicate a stronger correlation between BIA-ALCL and textured breast implants. The FDA also announced the end of their medical device alternative summary reporting system.
Health FeaturesOklahoma Opioid Trial Reveals Johnson & Johnson Pushed Opioids
James Parker · June 25, 2019
Oklahoma's latest opioid trial revealed that Johnson & Johnson pressured doctors to sell "more and more opioids." During proceedings, It also came to light that J&J heavily profited from its two subsidiaries Noramco and Tasmanian Alkaloids - major players in U.S. opioid epidemic.
Legal DevelopmentsHow to Stay Safe with Electric Gate Systems
James Parker · June 26, 2018
In the past 20 years, hundreds of people around the world have been injured or killed by an electric gate. Understanding automatic gate safety is key for both businesses and homeowners.
Health FeaturesNew Calorie Labels in Restaurants May Be Useful in the Fight Against Obesity
James Parker · June 1, 2018
Since early May, all restaurants with more than 20 locations are required to add calorie labels to their menus.
NewsA MedTruth Guide to Diabetic Neuropathy
James Parker · May 23, 2018
Our guide to diabetic neuropathy delves into different types of nerve damage, associated symptoms and potential treatment options.
Health FeaturesDoctors Need More Info to Choose the Best Mesh for Hernia Repair
James Parker · May 21, 2018
A recent study shows hernia mesh labels lack important info, which could increase the risk of complications for patients.
Health FeaturesAre Diabetes and Depression Linked?
James Parker · July 19, 2018
Depression is the leading cause of disability worldwide. For diabetics, it can have a big impact on safety and self-care.
Health FeaturesFDA Dismissed Citizen Petition for Plavix Labeling
James Parker · January 18, 2019
The FDA recently dismissed a petition to add a new black-box label to the popular blood thinner Plavix.
FDA RegulationReuters Exposes How Johnson & Johnson Covered Up Asbestos in Talc
James Parker · December 18, 2018
An investigation shows Johnson & Johnson hid the fact that trace amounts of asbestos has been detected in their talc for decades.
NewsFDA Announces Intent to Look Into Potential “Vape Seizures”
James Parker · April 4, 2019
The U.S. Food and Drug Administration (FDA) announced today that they would begin looking into a potential link in a series of vape seizures that seem to be affecting young adults. The FDA became aware of the issue when conducting reviews of adverse event reporting related to vape use as part of their initiative to fully define the direct and indirect risks associated with the product.
FDA RegulationFDA Warns of Rare Genital Gangrene Linked to SGLT2 Diabetes Drugs
James Parker · September 17, 2018
People with diabetes taking Invokana and other SGLT2 inhibitors may be at risk for Fournier's gangrene, a flesh-eating bacterial infection affecting the groin and genitals. SGLT2 inhibitors that may potentially cause Fournier's gangrene include Invokana, Farxiga and Jardiance.
FDA RegulationFDA Takes A Stand Against The Flood of Underage Juul Users
James Parker · September 12, 2018
As the use of Juul vaporizers and other e-cigarettes among teens rises, the FDA reviews the company's youth marketing efforts and fines retailers for selling to minors.
FDA Regulation22 Women Win Talcum Powder Cancer Case
James Parker · August 16, 2018
A Missouri jury awarded $4.69 billion to compensate women who reportedly developed talcum powder ovarian cancer, delivering the largest product-defect verdict in U.S. history.
Legal DevelopmentsFDA Warns of E-Cig Burns, Erectile Dysfunction Drugs in Vape Juice
James Parker · November 16, 2018
As the FDA struggles to regulate e-cigarette marker, the agency has warned against e-cig burns, device explosions and even liquids containing erectile dysfunction drugs.
FDA RegulationPurdue Settles for $270 Million in Oklahoma's Opioid Crisis
James Parker · April 17, 2019
The state of Oklahoma and Purdue Pharmaceuticals have agreed to a $270 million settlement to help combat the crippling issue of opioid addiction in rural America.
Legal DevelopmentsJ&J Mesothelioma Talc Verdict in New York May Exceed $25 Million
James Parker · May 22, 2019
A New York jury issued a $25 million verdict against J&J for its part in causing a 66-year-old woman's asbestos-related cancer. The woman, Donna Olson, used J&J's talc products for decades.
Legal DevelopmentsVanderbilt Tests VR Program To Treat Opioid Users
James Parker · April 23, 2018
An experimental therapy program, in development at Vanderbilt University, uses VR technology to treat opioid addiction.
MedTechPhilippine FDA Warns of Talc in Cosmetics
James Parker · April 30, 2018
The Philippine FDA recently issued a consumer advisory about potential asbestos contamination in cosmetic talcum powder.
FDA RegulationIs Scalp Cooling a Treatment for Taxotere Hair Loss?
James Parker · May 14, 2018
The emergence of a new therapy known as scalp cooling may help women worried about permanent hair loss from Taxotere and other chemotherapy drugs.
NewsPressure Cooker Recall: The Dangers of Defective Pressure Cookers
James Parker · June 8, 2018
A pressure cooker recall has been issued for multiple models that may explode, shock, or burn consumers. Because pressure cooker injuries can be serious, it's incredibly important to research recalled models and understand potential dangers.
NewsHalf the Nation Unites Against Opioid Manufacturer
James Parker · July 6, 2018
In a crackdown attempt to fight the opioid crisis, 26 states are taking legal action against a major OxyContin manufacturer.
Legal DevelopmentsSSRIs and Sex: How Antidepressants Affect Desire
James Parker · July 31, 2018
SSRIs are commonly prescribed to help people living with anxiety or depression. Unfortunately, there may be a sexual caveat to these medications.
Health Features